Menu

Agios Pharmaceuticals, Inc. AGIO

Full chart Compare
Set alert

Price alert · AGIO

All alert types
29.41 USD +1.14 (+4.03%)

At closeNov 6, 2026, 5:17 PM EST

28.97 -0.44 -1.50%

After hours · Nov 6, 5:17 PM ET

28.47 Day range 29.79
22.34 52-week range 45.49
YTD
+8.05%
1 year
-27.04%

Revenue & Expenses

Other Income → Expenses: $58.34MExpenses → Selling, General & Admin: $180.28MExpenses → Research & Development: $339.54MIncome Tax Benefit → Expenses: $1.02MGross Profit → Expenses: $47.68MRevenue → Gross Profit: $47.68MRevenue → Cost of Revenue: $6.34MNet Loss → Expenses: $412.78MOther Income$58.34MIncome Tax Benefit$1.02MGross Profit$47.68MNet Loss$412.78MCost of Revenue$6.34MExpenses$519.82MSelling, General & Admin$180.28MResearch & Development$339.54MRevenue$54.03M

Latest period ending Dec 31, 2025 · select a line to chart its full history

AGIO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
54.03M36.50M26.82M14.24M0
47.68M32.33M23.94M12.54M0
-472.13M463.40M-391.49M-251.34M-371.78M
-412.78M673.73M-352.09M-231.80M1.60B
-7.1211.64-6.33-4.2326.55
AGIO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
89.13M76.25M88.20M139.26M203.13M
1.30B1.66B937.12M1.24B1.44B
104.11M122.24M126.10M137.90M145.76M
40.21M56.99M72.00M85.66M97.09M
1.19B1.54B811.02M1.10B1.29B
AGIO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-372.98M-389.84M-296.06M-309.48M-407.32M
377.18M363.44M239.57M243.26M1.25B
8.68M14.44M5.43M2.35M-765.77M
-4.32M-1.65M326.00K-3.92M-5.74M
12.88M-11.96M-51.05M-63.87M75.69M